Explore our solutions
Globally leading life sciences companies trust us
A Broad Range of Clinical Services
Digital Hybrid Registries / NIS
- Full-service Phase IV studies
- Continuous PRO collection
- Low site workload
- Operational support
Feasibility & Data Analytics
- Endpoint validation
- Patient & therapy pathways
- Adherence
- Subgroups
Patient Support
- Branded educational modules
- Tools to improve therapy adherence
- Digital therapy support
Community Access & Patient Recruitment
- Access to patient communities
- Direct patient communication
- Rapid recruitment
What Makes Midaia Unique
Rheumatology CRO with Its Own Patient Community
Direct access to a qualified, digitally connected rheumatology patient population enables the immediate launch of observational studies and NIS — without time-consuming recruitment processes. Faster study workflows and early, robust results.
Real-World Data Through the Mida Rheuma App
Through the Mida Rheuma App, patient-reported outcomes (PROs), therapy progressions, symptoms, quality of life, and medication data are continuously, systematically, and longitudinally collected. This creates high-quality real-world data from rheumatology care.
Clinical Best Practice & Robust Data Analytics
Midaia conducts studies in accordance with ICH-GCP, regulatory requirements, and clinical best practices. The resulting data and analyses provide valid real-world evidence, complemented by market and patient population data — directly usable for Medical Affairs and Market Access.
The Mida Rheuma App
For Patients: More Overview, More Engagement, Better Quality of Life
The Mida Rheuma App supports people with inflammatory rheumatic diseases in actively managing and documenting their condition. At the same time, they become part of a secure patient community that actively contributes to clinical research.
- Documentation of symptoms, pain, and disease activity
- Tracking of therapy progression and quality of life
- Improved therapy adherence through digital support
- Active participation in observational studies and NIS
- Transparent handling of personal health data
For Clinical Research: Digital Study Platform for Rheumatology Research
For pharmaceutical companies and research partners, the Mida Rheuma App is a validated digital infrastructure for conducting patient-centered studies in rheumatology. It enables direct access to an existing patient population.
- Direct integration of a qualified rheumatology patient population
- Real-time collection of real-world data
- Structured collection of PROs and longitudinal data
- Longitudinal datasets from real-world care
- Accelerated execution of observational studies and NIS
Mida Rheuma App in Numbers
Patients Supported
0
Less Pain and Symptoms
0 %
Of Users Are Highly Satisfied
0 %
About us
Midaia unites patient-centric digital health solutions with clinical research excellence. Through the Mida Rheuma App, we support individuals living with rheumatic conditions in daily disease management and simultaneously create evidence through real-world research that drives more personalized therapies with measurable benefits for patients.
The Team
“I would be happy to present the advantages of a partnership with Midaia in a personal meeting.”
Felix Lang, Midaia
Strengthening rheumatology research through patient-centered innovation.
Midaia bridges the gap between clinical excellence and digital speed, offering a comprehensive ecosystem for Phase IV studies, real-world data, and patient engagement.
.